Global 2'-OMe-Ibu-G Phosphoramidite Market Growth 2025-2031

Global 2'-OMe-Ibu-G Phosphoramidite Market Growth 2025-2031

The global 2'-OMe-Ibu-G Phosphoramidite market size is predicted to grow from US$ 2.1 million in 2025 to US$ 3.5 million in 2031; it is expected to grow at a CAGR of 9.2% from 2025 to 2031.

2'-OMe-Ibu-G Phosphoramidite (CAS 150780-67-9) is a white to off-white powder. It is a pharmaceutical intermediate and can be used to synthesize RNA.

The 2'-OMe-Ibu-G Phosphoramidite market is experiencing notable growth due to its increasing demand in the field of oligonucleotide synthesis. This specialized compound is widely used in the development of RNA-based therapeutics, including antisense oligonucleotides (ASOs), small interfering RNA (siRNA), and mRNA vaccines. As RNA-based therapies gain momentum in treating genetic disorders, cancers, and infectious diseases, the demand for high-quality phosphoramidites like 2'-OMe-Ibu-G, which improves stability and reduces immunogenicity in oligonucleotides, has surged. The COVID-19 pandemic, which accelerated RNA vaccine development, has also contributed to the expanding market for these key chemical building blocks.

Another driving force behind the market growth is the rising investment in biopharmaceutical research and development. As pharmaceutical companies and research institutes explore innovative RNA-based treatments, there is a need for more reliable and efficient oligonucleotide synthesis reagents like 2'-OMe-Ibu-G Phosphoramidite. This compound's ability to enhance the stability of RNA sequences by providing protection against enzymatic degradation has made it a preferred choice for scientists working on cutting-edge therapeutics. Moreover, as RNA technologies evolve, the market is seeing advancements in synthesis techniques, improving production scalability and reducing costs, making these materials more accessible for broader applications.

North America and Europe are currently leading the market due to their strong presence in the pharmaceutical and biotechnology sectors. However, Asia-Pacific is expected to witness significant growth, particularly as countries like China and India increase their investments in biotech research. Furthermore, regulatory bodies are offering incentives for companies developing RNA-based drugs, further bolstering market demand. With continued progress in RNA therapies, vaccine development, and gene editing technologies, the market for 2'-OMe-Ibu-G Phosphoramidite is expected to maintain a positive growth trajectory in the coming years.

LP Information, Inc. (LPI) ' newest research report, the “2'-OMe-Ibu-G Phosphoramidite Industry Forecast” looks at past sales and reviews total world 2'-OMe-Ibu-G Phosphoramidite sales in 2024, providing a comprehensive analysis by region and market sector of projected 2'-OMe-Ibu-G Phosphoramidite sales for 2025 through 2031. With 2'-OMe-Ibu-G Phosphoramidite sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world 2'-OMe-Ibu-G Phosphoramidite industry.

This Insight Report provides a comprehensive analysis of the global 2'-OMe-Ibu-G Phosphoramidite landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on 2'-OMe-Ibu-G Phosphoramidite portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global 2'-OMe-Ibu-G Phosphoramidite market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for 2'-OMe-Ibu-G Phosphoramidite and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global 2'-OMe-Ibu-G Phosphoramidite.

This report presents a comprehensive overview, market shares, and growth opportunities of 2'-OMe-Ibu-G Phosphoramidite market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Purity above 98%
Purity above 99%
Others

Segmentation by Application:
Laboratory
Pharmaceutical

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Merck
Hongene Biotech
Biosynth Carbosynth
BLD Pharmatech
BOC Sciences
LGC Standards
Glen Research
TCI
Wuhu Huaren Science and Technology
Thermo Scientific
Chemtour

Key Questions Addressed in this Report

What is the 10-year outlook for the global 2'-OMe-Ibu-G Phosphoramidite market?

What factors are driving 2'-OMe-Ibu-G Phosphoramidite market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do 2'-OMe-Ibu-G Phosphoramidite market opportunities vary by end market size?

How does 2'-OMe-Ibu-G Phosphoramidite break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.